HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.
Serwanga J, Ssemwanga D, Muganga M, Nakiboneka R, Nakubulwa S, Kiwuwa-Muyingo S, Morris L, Redd AD, Quinn TC, Kaleebu P; HIV Superinfection Study Group.
Serwanga J, et al.
Vaccine. 2018 Jan 25;36(4):578-586. doi: 10.1016/j.vaccine.2017.11.075. Epub 2017 Dec 20.
Vaccine. 2018.
PMID: 29274699